InMed Pharmaceuticals Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN), in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs.
Ticker:
INM
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
British Columbia
Company HQ Country:
Canada
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
INM 755 in dermatology, INM 088 in ocular disease
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President & CEO
InMed Pharmaceuticals